• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】15361

【品名】4-Aminobenzonitrile

【CA登记号】873-74-5

【 分 子 式 】C7H6N2

【 分 子 量 】118.13812

【元素组成】C 71.17% H 5.12% N 23.71%

与该中间体有关的原料药合成路线共 11 条

合成路线1

该中间体在本合成路线中的序号:(II)

By condensation of 4-chloro-6,7-dihydro-5H-cyclopenta[dlpyrimidine (I) with 4-cyanoaniline (II) in ethanol at 130 C.

1 Kamioka, T.; et al. (Sankyo Co., Ltd.; Ube Industries, Ltd.); Pyrimidine derivatives and a pharmaceutical composition containing them. CA 1169861; EP 0067630; JP 57203072; US 4450162 .
2 Serradell, M.N.; Castaner, J.; RS-2232. Drugs Fut 1985, 10, 6, 469.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29674 4-chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidine C7H7ClN2 详情 详情
(II) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

Coupling between 4-cyanobenzoyl chloride (I) and 4-aminobenzonitrile (II) in the presence of Et3N afforded the corresponding amide (III). The dicyano compound (III) was then treated with sodium azide and ammonium chloride in hot DMF to produce the title bis-tetrazolyl derivative.

1 Makovec, F.; Peris, W.; Rovati, A.L. (Rotta Research Laboratorium SpA); Derivs. of N-phenylbenzamide with anti-ulcer and anti-allergy activity and a method for their preparation. EP 0460083; JP 1992503514; US 5232937; WO 9009989 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19280 4-cyanobenzoyl chloride 6068-72-0 C8H4ClNO 详情 详情
(II) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(III) 48057 4-cyano-N-(4-cyanophenyl)benzamide C15H9N3O 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

The condensation of 2-[3-ethoxy-4-(ethoxycarbonyl)phenyl]acetic acid (I) with 3-methyl-1(S)-(2-(1-piperidinyl)phenyl)butylamine (II) by activation with pivaloyl chloride and TEA in toluene gives the corresponding amide (III), which is finally hydrolyzed by means of NaOH water/denaturated spirit to afford the target Repaglinide.

1 Kumar, N.; Salman, M.; Ray, P.C.; Babu, J.S. (Ranbaxy Laboratories Ltd.); Process for the preparation of repaglinide. WO 0327072 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15301 2-[3-ethoxy-4-(ethoxycarbonyl)phenyl]acetic acid C13H16O5 详情 详情
(II) 15315 (1S)-3-methyl-1-(2-piperidinophenyl)butylamine; (1S)-3-methyl-1-(2-piperidinophenyl)-1-butanamine C16H26N2 详情 详情
(III) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The synthesis of BBE was accomplished using a modified version of a published procedure, as outlined in Scheme 17960101a: Following acetylation (II) of the amine group, 4-aminobenzonitrile (I) was nitrated with potassium nitrate and the acetyl group removed with boiling sulfuric acid to give the mono-nitro product (III). The nitrile was converted to the corresponding amidine in two steps via the Pinner amidine synthesis (1, 2) to give 4-amino-3-nitrobenzamidine (IV). Reduction of the nitro group with 10% Pd-C in a Parr hydrogenator afforded a 60% yield (from compound I) of 3,4-diaminobenzamidine (V). The di-imidate (VII) of fumaronitrile (VI) was prepared by reacting the dinitrile in freshly distilled ethanol with dry HCl gas at 10 C. The di-imidate (VII) was reacted immediately with a 1/2 molar equivalent of 3,4-diaminobenzamidine in refluxing glacial acetic acid. The final product was isolated by trituration with ethyl acetate and filtration. BBE was purified by two recrystallizations from 4% HCl. The yield of the purified product was 15%.

1 Tidwell, R.R.; Geratz, J.D.; BBE. Drugs Fut 1992, 17, 5, 371.
2 Dann, O.; Volz, G.; Loewe, H.; Zeh, D.; Tidwell, R.R.; Geratz, J.D.; Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. J Med Chem 1978, 21, 7, 613-23.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(II) 15362 N-(4-cyanophenyl)acetamide 35704-19-9 C9H8N2O 详情 详情
(III) 15363 4-amino-3-nitrobenzonitrile 6393-40-4 C7H5N3O2 详情 详情
(IV) 15364 4-amino-3-nitrobenzenecarboximidamide C7H8N4O2 详情 详情
(V) 15365 3,4-diaminobenzenecarboximidamide C7H10N4 详情 详情
(VI) 15366 fumaronitrile; (E)-2-butenedinitrile 17656-09-6 C4H2N2 详情 详情
(VII) 15367 diethyl (E)-2-butenediimidoate C8H14N2O2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

The condensation of 4-aminobenzonitrile (I) with the chiral 2,3-epoxypropanol (II) in refluxing methanol gives 4-(2,3-dihydroxypropylamino)benzonitrile (III), which is cyclized with diethyl carbonate (IV) by means of tBu-OK at 100 C to yield the oxazolidinone (V). The reaction of the cyano group of (V) with hydroxylamine in methanol affords the N-hydroxyamidine (VI), which is cyclized with Ac2O at 120 C to provide the 1,2,4-oxadiazole (VII). The hydrolysis of the acetoxy group of (VII) with K2CO3 in refluxing methanol gives the primary alcohol (VIII), which is treated with Ms-Cl and pyridine to yield the corresponding mesylate (IX). The condensation of (IX) with 2-(1-piperazinyl)acetic acid ethyl ester (X) in refluxing acetonitrile affords the adduct (XI), which is hydrogenated with H2 over Pd/C and hydrolyzed with HOAc to obtain the benzamidine derivative (XII). Finally, this compound is acylated with methyl chloroformate (XIII) and NaOH in dichloromethane/water.

1 Gante, J.; et al.; New antithrombotic RGD-mimetics with bioavailability. Bioorg Med Chem Lett 1996, 6, 20, 2425.
2 Gante, J.; Juraszyk, H.; Raddatz, P.; Wurziger, H.; Bernotat-Danielowski, S.; Melzer, G. (Merck Patent GmbH); Adhesion receptor antagonists. CA 2175767; DE 19516483; EP 0741133; JP 1996301857; US 6455529 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(II) 19241 (2S)oxiranylmethanol 60456-23-7 C3H6O2 详情 详情
(III) 54669 4-{[(2S)-2,3-dihydroxypropyl]amino}benzonitrile C10H12N2O2 详情 详情
(IV) 17470 diethyl carbonate; diethylcarbonate 105-58-8 C5H10O3 详情 详情
(V) 54670 4-[(5S)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]benzonitrile C11H10N2O3 详情 详情
(VI) 54671 N'-hydroxy-4-[(5S)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]benzenecarboximidamide C11H13N3O4 详情 详情
(VII) 54672 {(5S)-3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl acetate C15H15N3O5 详情 详情
(VIII) 54673 (5S)-5-(hydroxymethyl)-3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1,3-oxazolidin-2-one C13H13N3O4 详情 详情
(IX) 54674 {(5S)-3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl methanesulfonate C14H15N3O6S 详情 详情
(X) 54675 1-(Ethoxycarbonylmethyl)piperazine; N-(Carboethoxymethyl)piperazine; (1-Piperazino)acetic acid ethyl ester 40004-08-8 C8H16N2O2 详情 详情
(XI) 54676 ethyl 2-[4-({(5R)-3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)-1-piperazinyl]acetate C21H27N5O5 详情 详情
(XII) 54677 ethyl 2-{4-[((5R)-3-{4-[amino(imino)methyl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]-1-piperazinyl}acetate C19H27N5O4 详情 详情
(XIII) 16993 methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate 79-22-1 C2H3ClO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IV)

Alkylation of methyl 4-oxo-3-piperidinecarboxylate (I) with ethyl bromoacetate provided piperidineacetate (II). Subsequent decarbomethoxylation of (II) using LiCl in boiling DMF produced piperidone (III). On the other hand, coupling between 4-aminobenzonitrile (IV) and N-Boc-glycine (V) via activation with carbonyldiimidazole gave amide (V). The Boc group of (V) was then deprotected with HCl in EtOAc to yield 2-amino-N-(4-cyanophenyl)acetamide (VI). Reductive condensation of amine (VI) with piperidone (III) employing NaBH(OAc)3 furnished adduct (VII), which was further reductocondensed with chloroacetaldehyde to give chloroethyl amine (VIII). Cyclization of (VIII) in the presence of NaH generated piperazinone (IX). Finally, addition of hydroxylamine to the cyano group of (IX) provided the corresponding hydroxyamidine.

1 Suzuki, K.; Tsukamoto, S.; Yanagisawa, I.; Matsumoto, Y.; Ichihara, M.; Akamatsu, S.; Kaku, S.; Kawasaki, T.; Novel orally active GPIIb/IIIa antagonists: Synthesis and structure-activity relationship studies of oxopiperazine derivatives. Symp Med Chem 1999, Abst 1P-02.
2 Matsumoto, Y.; Akamatsu, S.; Ichihara, M.; Kawasaki, T.; Kaku, S.; Yanagisawa, I. (Merck Patent GmbH; Yamanouchi Pharmaceutical Co., Ltd.); Substd. amidinobenzene derivs. and medicinal compsns. thereof. EP 0905129; US 6057324; WO 9745413 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
18066 N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid 4530-20-5 C7H13NO4 详情 详情
(I) 28106 methyl 4-oxo-3-piperidinecarboxylate 56026-52-9 C7H11NO3 详情 详情
(II) 37983 methyl 1-(2-ethoxy-2-oxoethyl)-4-oxo-3-piperidinecarboxylate C11H17NO5 详情 详情
(III) 37984 ethyl 2-(4-oxo-1-piperidinyl)acetate C9H15NO3 详情 详情
(IV) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(V) 37985 tert-butyl 2-(4-cyanoanilino)-2-oxoethylcarbamate C14H17N3O3 详情 详情
(VI) 37986 2-amino-N-(4-cyanophenyl)acetamide C9H9N3O 详情 详情
(VII) 37988 ethyl 2-(4-[[2-(4-cyanoanilino)-2-oxoethyl]amino]-1-piperidinyl)acetate C18H24N4O3 详情 详情
(VIII) 37987 ethyl 2-(4-[(2-chloroethyl)[2-(4-cyanoanilino)-2-oxoethyl]amino]-1-piperidinyl)acetate C20H27ClN4O3 详情 详情
(IX) 37989 ethyl 2-[4-[4-(4-cyanophenyl)-3-oxo-1-piperazinyl]-1-piperidinyl]acetate C20H26N4O3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(II)

The synthesis can be performed by two related ways: 1) The condensation of 2-(methylsulfanyl)pyrimidin-4-ol (I) with 4-aminobenzonitrile (II) in hot diglyme gives 4-(4-hydroxypyrimidin-2-ylamino)benzonitrile (III), which is treated with POCl3 to yield the corresponding chloro derivative (IV). Finally, this compound is condensed with 2,4,6-trimethylaniline (V) in dioxane to afford the target 4-aminobenzonitrile derivative. 2) Condensation of 2,4,6-trimethylaniline (VI) with 2,4-dichloropyrimidine (VII) by means of DIEA in refluxing 1,4-dioxane, followed by chromatographic purification furnishes intermediate (VIII), which is finally converted into the desired compound by condensation with 4-aminobenzonitrile (II) in refluxing water by means of HCl in 2-propanol.

2 Heeres, J.; Kukla, M.J.; Andries, K.J.L.M.; Janssen, P.A.J.; Ho, C.Y.; Janssen, M.A.C.; Ludovici, D.W.; de Corte, B.; de Jonge, M.R.; Koymans, L.M.H.; van Aken, K.J.A. (Janssen Pharmaceutica NV); HIV inhibiting pyrimidine derivs.. EP 0945442; EP 0945443; US 6197779; US 6440986; WO 9950250 .
1 Ludovici, D.W.; De Corte, B.L.; Kukla, M.J.; et al.; Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. Bioorg Med Chem Lett 2001, 11, 17, 2235.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54374 2-Methylsulfanylpyrimidin-4-ol; 2-Methylthio-4-hydroxy pyrimidine 124700-70-5 C5H6N2OS 详情 详情
(II) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(III) 54375 4-[(4-hydroxy-2-pyrimidinyl)amino]benzonitrile; 4-[(1,4-Dihydro-4-oxo-2-pyrimidinyl)amino]benzonitrile 189956-45-4 C11H8N4O 详情 详情
(IV) 54376 4-[(4-chloro-2-pyrimidinyl)amino]benzonitrile 244768-32-9 C11H7ClN4 详情 详情
(V) 28804 2,4,6-trimethylaniline 88-05-1 C9H13N 详情 详情
(VII) 54377 2,4-Dichloropyrimidine 3934-20-1 C4H2Cl2N2 详情 详情
(VIII) 54378 2-chloro-N-mesityl-4-pyrimidinamine; N-(2-chloro-4-pyrimidinyl)-N-mesitylamine C13H14ClN3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The reaction of 5-bromo-2,4,6-trichloropyrimidine (I) with 4-aminobenzonitrile (II) by means of DIEA in refluxing dioxane gives the diarylamine (III), which is condensed with 4-hydroxy-3,5-dimethylbenzonitrile (IV) by means of NaH in NMP to yield the corresponding adduct (V). Finally, this compound is treated with ammonia in dioxane at 150 C in a pressure vessel.

1 Heeres, J.; De Corte, B.; Kukla, M.J.; Van Aken, K.J.A.; Janssen, P.A.J.; Ludovici, D.W.; De Jonge, M.R.; Kavash, R.W.; Ho, C.Y.; Koymans, L.M.H. (Janssen Pharmaceutica NV); HIV replication inhibiting pyrimidines. EP 1002795; WO 0027825 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46616 5-bromo-2,4,6-trichloropyrimidine C4BrCl3N2 详情 详情
(II) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(III) 46617 4-[(5-bromo-4,6-dichloro-2-pyrimidinyl)amino]benzonitrile C11H5BrCl2N4 详情 详情
(IV) 31141 4-Hydroxy-3,5-dimethylbenzonitrile; 2,6-Dimethyl-4-hydroxybenzonitrile 4198-90-7 C9H9NO 详情 详情
(V) 46618 4-[[5-bromo-6-chloro-2-(4-cyanoanilino)-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile C20H13BrClN5O 详情 详情

合成路线9

该中间体在本合成路线中的序号:(VII)

Alkylation of 4-hydroxybenzaldehyde (I) with iodoacetic acid afforded 4-formylphenoxyacetic acid (II). This was condensed with 5,6-diamino-1,3-dipropyluracil (III) to produce imine (IV), which was oxidatively cyclized to xanthine (V) in the presence of ferric chloride. After activation of (V) as the corresponding acid chloride (VI), coupling with 4-aminobenzonitrile (VII) furnished the title amide.

1 Jacobson, K.A.; et al.; Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem 1985, 28, 9, 1334-40.
2 Ji, X.; Kim, Y.-C.; Linden, J.; Jacobson, K.A.; Melman, N.; Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors. J Med Chem 2000, 43, 6, 1165.
3 Kim, Y.-C.; Linden, J.M.; Jocobson, K.A. (University of Virginia); Substd. 8-phenylxanthines useful as antagonists of A2B adenosine receptors. WO 0073307 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
40086 2-iodoacetic acid 64-69-7 C2H3IO2 详情 详情
(I) 13433 4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde 123-08-0 C7H6O2 详情 详情
(II) 25513 2-(4-Formylphenoxy)acetic acid; 4-Formyl phenoxy acetic acid 22042-71-3 C9H8O4 详情 详情
(III) 14628 5,6-diamino-1,3-dipropyl-2,4(1H,3H)-pyrimidinedione C10H18N4O2 详情 详情
(IV) 35608 2-(4-[[(6-amino-2,4-dioxo-1,3-dipropyl-1,2,3,4-tetrahydro-5-pyrimidinyl)imino]methyl]phenoxy)acetic acid C19H24N4O5 详情 详情
(V) 44758 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetic acid C19H22N4O5 详情 详情
(VI) 44759 2-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetyl chloride C19H21ClN4O4 详情 详情
(VII) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(IV)

 

1 Shashikant J, Golak CM, Shyam T, et al. 2010. An improved synthesis of etravirine. Orangic Process Research & Development, 14: 657~660.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43734 2,4,6-trichloropyrimidine 3764-01-0 C4HCl3N2 详情 详情
(II) 31141 4-Hydroxy-3,5-dimethylbenzonitrile; 2,6-Dimethyl-4-hydroxybenzonitrile 4198-90-7 C9H9NO 详情 详情
(III) 67127 4-((2,6-dichloropyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile 4198-90-7 C13H9Cl2N3O 详情 详情
(IV) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(V) 67128 4-((4-(4-(aminomethyl)-2,6-dimethylphenoxy)-6-chloropyrimidin-2-yl)amino)benzonitrile   C20H14ClN5O 详情 详情
(VI) 67129 4-((6-((4-(aminomethyl)phenyl)amino)-2-chloropyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile    C20H14ClN5O 详情 详情

合成路线11

该中间体在本合成路线中的序号:(Ib)

Cyclization of 4-bromoaniline (Ia) with methyl vinyl ketone (II) by means of H2SO4 in refluxing dioxane affords 6-bromo-4-methylquinoline (IIIa) (1). Similarly, cyclization of 4-aminobenzonitrile (Ib) with methyl vinyl ketone (II) by means of HCl and chloranil in EtOH gives 4-methyl-6-quinolinecarbonitrile (IIIb) (2). Condensation of 4-methylquinolines (IIIa) or (IIIb) with methyl 6-methylpyridine-2-carboxylate (IV) by means of KHMDS in THF at –70 °C or t-BuONa in THF (2) produces the 2-(4-quinolinyl)-1-(pyridyl)ethanone derivatives (Va) (1) or (Vb) (2), respectively. Subsequent condensation of ketone (Va) with 1-amino-2-pyrrolidinone hydrochloride (VIa) in pyridine yields acyl hydrazone (VIIa), which is cyclized by means of Cs2CO3 in DMF at 100 °C, leading to the pyrrolopyrazole derivative (IXa) (1). Alternatively, condensation of ketone (Vb) with 1-amino-2-pyrrolidinone p-toluenesulfonate (VIb) [prepared by the hydrolysis of hydrazone (VIII) with p-TsOH·H2O in toluene] in the presence of 2,6-lutidine in refluxing DMF/toluene provides the acyl hydrazone (VIIb), which cyclizes to the pyrrolopyrazole derivative (IXb) by treatment with K2CO3 (2). Finally, methoxycarbonylation of bromoquinoline (IXa) under CO atmosphere in the presence of Pd(dppf)2Cl2 and NaOAc in MeOH at 80 °C gives the methyl ester (X), which is submitted to ammonolysis with NH3 in MeOH at 90 °C. Alternatively, nitrile (IXb) is hydrolyzed by means of H2O2 and K2CO3 in DMSO/H2O .

1 Beight, D.W., Yingling, J.M., Sawyer, J.S. (Eli Lilly and Company). Quinolinyl-pyrrolopyrazoles. CA 2501322, EP 1565471, JP 2006514012, US 2006040983, US 7265225, WO 2004048382.
2 Mundla, S.R. (Eli Lilly and Company). A pyridine quinolin substituted pyrrolo[1,2-b]pyrazole monohydrate as TGF-beta inhibitor. EP 19103
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Ia) 22531 4-Bromoaniline; 4-Bromophenylamine 106-40-1 C6H6BrN 详情 详情
(Ib) 15361 4-Aminobenzonitrile 873-74-5 C7H6N2 详情 详情
(IIIa) 67742 6-bromo-4-methylquinoline 41037-28-9 C10H8BrN 详情 详情
(IIIb) 67743 4-methyl-6-quinolinecarbonitrile   C11H8N2 详情 详情
(Va) 67744 2-(6-bromoquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone   C17H13BrN2O 详情 详情
(Vb) 67745 4-(2-(6-methylpyridin-2-yl)-2-oxoethyl)quinoline-6-carbonitrile   C18H13N3O 详情 详情
(VIa) 67746 1-amino-2-pyrrolidinone hydrochloride 20386-22-5 C4H8N2O.HCl 详情 详情
(VIb) 67747 1-aminopyrrolidin-2-one 4-methylbenzenesulfonate   C7H83S.C4H8N2O 详情 详情
(VIIa) 67749 (E)-1-((2-(6-bromoquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethylidene)amino)pyrrolidin-2-one   C21H19BrN4O 详情 详情
(VIIb) 67748 (E)-4-(2-(6-methylpyridin-2-yl)-2-((2-oxopyrrolidin-1-yl)imino)ethyl)quinoline-6-carbonitrile   C22H19N5O 详情 详情
(IXa) 67751 6-bromo-4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline   C21H17BrN4 详情 详情
(IXb) 67752 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrile   C22H17N5 详情 详情
(II) 30324 3-buten-2-one; methyl vinyl ketone 78-94-4 C4H6O 详情 详情
(IV) 62758 methyl 6-methyl-2-pyridinecarboxylate 13602-11-4 C8H9NO2 详情 详情
(VIII) 67750 1-((diphenylmethylene)amino)pyrrolidin-2-one   C17H16N2O 详情 详情
(X) 67753 methyl 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxylate   C23H20N4O2 详情 详情
Extended Information